# Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients

> **NCT00496483** · PHASE2 · COMPLETED · sponsor: **Veloxis Pharmaceuticals** · enrollment: 60 (actual)

## Conditions studied

- Renal Failure

## Interventions

- **DRUG:** LCP Tacro (tacrolimus)
- **DRUG:** Prograf

## Key facts

- **NCT ID:** NCT00496483
- **Lead sponsor:** Veloxis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496483, "Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00496483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*